Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001193125-26-267611

Options or other derivatives

  • Director acquired 72,323 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Clark William D Director 2026-06-09 Grant or award · Stock Option (Right to Buy) +70,000 70,000 D
Clark William D Director 2026-06-09 Grant or award · Stock Option (Right to Buy) +2,323 2,323 D
Loading xslF345X06/ownership.xml…